Click for best price
Valvular Heart Disease Treatment Market Size, Share 2022
Valvular heart disease is characterized by damage to or a defect in one of the four heart valves namely the mitral valve, aortic valve, tricuspid valve, and pulmonary valve.
This report contains market size and forecasts of Valvular Heart Disease Treatment in Global, including the following market information:
Global Valvular Heart Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Valvular Heart Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cardiac Catheterization Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Valvular Heart Disease Treatment include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc. and Micro Interventional Devices, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Valvular Heart Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Valvular Heart Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Valvular Heart Disease Treatment Market Segment Percentages, by Type, 2021 (%)
- Cardiac Catheterization
- Electrocardiogram (ECG)
- Chest X-Ray
- Stress Test
- Others
Global Valvular Heart Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Valvular Heart Disease Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital & Clinics
- Ambulatory Surgical Centers
- Research Institutes
Global Valvular Heart Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Valvular Heart Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Valvular Heart Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Valvular Heart Disease Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corp.
- Medtronic
- CryoLife Inc.
- Edwards Lifesciences Corporation
- LivaNova PLC
- Neovasc Inc.
- Micro Interventional Devices
- Symetis SA
- Jenavalve Technology
- TTK Healthcare Limited
- Colibri Heart Valve
- Lepu Medical Technology Co.
- Braile Biom?dica
| Report Attributes |
Report Details |
| Report Title |
Valvular Heart Disease Treatment Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Valvular Heart Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Valvular Heart Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Valvular Heart Disease Treatment Overall Market Size
2.1 Global Valvular Heart Disease Treatment Market Size: 2021 VS 2028
2.2 Global Valvular Heart Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Valvular Heart Disease Treatment Players in Global Market
3.2 Top Global Valvular Heart Disease Treatment Companies Ranked by Revenue
3.3 Global Valvular Heart Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Valvular Heart Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Valvular Heart Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Valvular Heart Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Valvular Heart Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Valvular Heart Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Valvular Heart Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 Cardiac Catheterization
4.1.3 Electrocardiogram (ECG)
4.1.4 Chest X-Ray
4.1.5 Stress Test
4.1.6 Others
4.2 By Type - Global Valvular Heart Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Valvular Heart Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Valvular Heart Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Valvular Heart Disease Treatment Market Size, 2021 & 2028
5.1.2 Hospital & Clinics
5.1.3 Ambulatory Surgical Centers
5.1.4 Research Institutes
5.2 By Application - Global Valvular Heart Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Valvular Heart Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Valvular Heart Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Valvular Heart Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Valvular Heart Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Valvular Heart Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Valvular Heart Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Valvular Heart Disease Treatment Revenue, 2017-2028
6.3.2 US Valvular Heart Disease Treatment Market Size, 2017-2028
6.3.3 Canada Valvular Heart Disease Treatment Market Size, 2017-2028
6.3.4 Mexico Valvular Heart Disease Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Valvular Heart Disease Treatment Revenue, 2017-2028
6.4.2 Germany Valvular Heart Disease Treatment Market Size, 2017-2028
6.4.3 France Valvular Heart Disease Treatment Market Size, 2017-2028
6.4.4 U.K. Valvular Heart Disease Treatment Market Size, 2017-2028
6.4.5 Italy Valvular Heart Disease Treatment Market Size, 2017-2028
6.4.6 Russia Valvular Heart Disease Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Valvular Heart Disease Treatment Market Size, 2017-2028
6.4.8 Benelux Valvular Heart Disease Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Valvular Heart Disease Treatment Revenue, 2017-2028
6.5.2 China Valvular Heart Disease Treatment Market Size, 2017-2028
6.5.3 Japan Valvular Heart Disease Treatment Market Size, 2017-2028
6.5.4 South Korea Valvular Heart Disease Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Valvular Heart Disease Treatment Market Size, 2017-2028
6.5.6 India Valvular Heart Disease Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Valvular Heart Disease Treatment Revenue, 2017-2028
6.6.2 Brazil Valvular Heart Disease Treatment Market Size, 2017-2028
6.6.3 Argentina Valvular Heart Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Valvular Heart Disease Treatment Revenue, 2017-2028
6.7.2 Turkey Valvular Heart Disease Treatment Market Size, 2017-2028
6.7.3 Israel Valvular Heart Disease Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Valvular Heart Disease Treatment Market Size, 2017-2028
6.7.5 UAE Valvular Heart Disease Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Valvular Heart Disease Treatment Major Product Offerings
7.1.4 Abbott Laboratories Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 B. Braun Melsungen AG
7.2.1 B. Braun Melsungen AG Corporate Summary
7.2.2 B. Braun Melsungen AG Business Overview
7.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Major Product Offerings
7.2.4 B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.2.5 B. Braun Melsungen AG Key News
7.3 Boston Scientific Corp.
7.3.1 Boston Scientific Corp. Corporate Summary
7.3.2 Boston Scientific Corp. Business Overview
7.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Major Product Offerings
7.3.4 Boston Scientific Corp. Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.3.5 Boston Scientific Corp. Key News
7.4 Medtronic
7.4.1 Medtronic Corporate Summary
7.4.2 Medtronic Business Overview
7.4.3 Medtronic Valvular Heart Disease Treatment Major Product Offerings
7.4.4 Medtronic Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.4.5 Medtronic Key News
7.5 CryoLife Inc.
7.5.1 CryoLife Inc. Corporate Summary
7.5.2 CryoLife Inc. Business Overview
7.5.3 CryoLife Inc. Valvular Heart Disease Treatment Major Product Offerings
7.5.4 CryoLife Inc. Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.5.5 CryoLife Inc. Key News
7.6 Edwards Lifesciences Corporation
7.6.1 Edwards Lifesciences Corporation Corporate Summary
7.6.2 Edwards Lifesciences Corporation Business Overview
7.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Major Product Offerings
7.6.4 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.6.5 Edwards Lifesciences Corporation Key News
7.7 LivaNova PLC
7.7.1 LivaNova PLC Corporate Summary
7.7.2 LivaNova PLC Business Overview
7.7.3 LivaNova PLC Valvular Heart Disease Treatment Major Product Offerings
7.7.4 LivaNova PLC Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.7.5 LivaNova PLC Key News
7.8 Neovasc Inc.
7.8.1 Neovasc Inc. Corporate Summary
7.8.2 Neovasc Inc. Business Overview
7.8.3 Neovasc Inc. Valvular Heart Disease Treatment Major Product Offerings
7.8.4 Neovasc Inc. Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.8.5 Neovasc Inc. Key News
7.9 Micro Interventional Devices
7.9.1 Micro Interventional Devices Corporate Summary
7.9.2 Micro Interventional Devices Business Overview
7.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Major Product Offerings
7.9.4 Micro Interventional Devices Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.9.5 Micro Interventional Devices Key News
7.10 Symetis SA
7.10.1 Symetis SA Corporate Summary
7.10.2 Symetis SA Business Overview
7.10.3 Symetis SA Valvular Heart Disease Treatment Major Product Offerings
7.10.4 Symetis SA Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.10.5 Symetis SA Key News
7.11 Jenavalve Technology
7.11.1 Jenavalve Technology Corporate Summary
7.11.2 Jenavalve Technology Business Overview
7.11.3 Jenavalve Technology Valvular Heart Disease Treatment Major Product Offerings
7.11.4 Jenavalve Technology Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.11.5 Jenavalve Technology Key News
7.12 TTK Healthcare Limited
7.12.1 TTK Healthcare Limited Corporate Summary
7.12.2 TTK Healthcare Limited Business Overview
7.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Major Product Offerings
7.12.4 TTK Healthcare Limited Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.12.5 TTK Healthcare Limited Key News
7.13 Colibri Heart Valve
7.13.1 Colibri Heart Valve Corporate Summary
7.13.2 Colibri Heart Valve Business Overview
7.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Major Product Offerings
7.13.4 Colibri Heart Valve Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.13.5 Colibri Heart Valve Key News
7.14 Lepu Medical Technology Co.
7.14.1 Lepu Medical Technology Co. Corporate Summary
7.14.2 Lepu Medical Technology Co. Business Overview
7.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Major Product Offerings
7.14.4 Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.14.5 Lepu Medical Technology Co. Key News
7.15 Braile Biom?dica
7.15.1 Braile Biom?dica Corporate Summary
7.15.2 Braile Biom?dica Business Overview
7.15.3 Braile Biom?dica Valvular Heart Disease Treatment Major Product Offerings
7.15.4 Braile Biom?dica Valvular Heart Disease Treatment Revenue in Global Market (2017-2022)
7.15.5 Braile Biom?dica Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Valvular Heart Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Valvular Heart Disease Treatment Market Drivers in Global Market
Table 3. Valvular Heart Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Valvular Heart Disease Treatment in Global Market
Table 5. Top Valvular Heart Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Valvular Heart Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Valvular Heart Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Valvular Heart Disease Treatment Product Type
Table 9. List of Global Tier 1 Valvular Heart Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Valvular Heart Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Valvular Heart Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Valvular Heart Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Valvular Heart Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Valvular Heart Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Valvular Heart Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Valvular Heart Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Valvular Heart Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Valvular Heart Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Valvular Heart Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Valvular Heart Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Valvular Heart Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Valvular Heart Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Valvular Heart Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Valvular Heart Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Valvular Heart Disease Treatment Product Offerings
Table 32. Abbott Laboratories Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. B. Braun Melsungen AG Corporate Summary
Table 34. B. Braun Melsungen AG Valvular Heart Disease Treatment Product Offerings
Table 35. B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Boston Scientific Corp. Corporate Summary
Table 37. Boston Scientific Corp. Valvular Heart Disease Treatment Product Offerings
Table 38. Boston Scientific Corp. Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Medtronic Corporate Summary
Table 40. Medtronic Valvular Heart Disease Treatment Product Offerings
Table 41. Medtronic Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. CryoLife Inc. Corporate Summary
Table 43. CryoLife Inc. Valvular Heart Disease Treatment Product Offerings
Table 44. CryoLife Inc. Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Edwards Lifesciences Corporation Corporate Summary
Table 46. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product Offerings
Table 47. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. LivaNova PLC Corporate Summary
Table 49. LivaNova PLC Valvular Heart Disease Treatment Product Offerings
Table 50. LivaNova PLC Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Neovasc Inc. Corporate Summary
Table 52. Neovasc Inc. Valvular Heart Disease Treatment Product Offerings
Table 53. Neovasc Inc. Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Micro Interventional Devices Corporate Summary
Table 55. Micro Interventional Devices Valvular Heart Disease Treatment Product Offerings
Table 56. Micro Interventional Devices Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Symetis SA Corporate Summary
Table 58. Symetis SA Valvular Heart Disease Treatment Product Offerings
Table 59. Symetis SA Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Jenavalve Technology Corporate Summary
Table 61. Jenavalve Technology Valvular Heart Disease Treatment Product Offerings
Table 62. Jenavalve Technology Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 63. TTK Healthcare Limited Corporate Summary
Table 64. TTK Healthcare Limited Valvular Heart Disease Treatment Product Offerings
Table 65. TTK Healthcare Limited Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Colibri Heart Valve Corporate Summary
Table 67. Colibri Heart Valve Valvular Heart Disease Treatment Product Offerings
Table 68. Colibri Heart Valve Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Lepu Medical Technology Co. Corporate Summary
Table 70. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product Offerings
Table 71. Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Braile Biom?dica Corporate Summary
Table 73. Braile Biom?dica Valvular Heart Disease Treatment Product Offerings
Table 74. Braile Biom?dica Valvular Heart Disease Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Valvular Heart Disease Treatment Segment by Type in 2021
Figure 2. Valvular Heart Disease Treatment Segment by Application in 2021
Figure 3. Global Valvular Heart Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Valvular Heart Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Valvular Heart Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Valvular Heart Disease Treatment Revenue in 2021
Figure 8. By Type - Global Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Valvular Heart Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Valvular Heart Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boston Scientific Corp. Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Medtronic Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. CryoLife Inc. Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. LivaNova PLC Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Neovasc Inc. Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Micro Interventional Devices Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Symetis SA Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Jenavalve Technology Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. TTK Healthcare Limited Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Colibri Heart Valve Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Braile Biom?dica Valvular Heart Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
